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Abstract
Objective: Shilajit is a pale-brown to blackish-brown organic mineral substance available from 
Himalayan rocks. We demonstrated that in type I obese humans, shilajit supplementation 
significantly upregulated extracellular matrix (ECM)–related genes in the skeletal muscle. Such an 
effect was highly synergistic with exercise. The present study (clinicaltrials.gov ) aimed to 
evaluate the effects of shilajit supplementation on skin gene expression profile and microperfusion 
in healthy adult females.
Methods: The study design comprised six total study visits including a baseline visit (V1) and a 
final 14-week visit (V6) following oral shilajit supplementation (125 or 250 mg bid). A skin 
biopsy of the left inner upper arm of each subject was collected at visit 2 and visit 6 for gene 
expression profiling using Affymetrix Clariom™ D Assay. Skin perfusion was determined by 
MATLAB processing of dermascopic images. Transcriptome data were normalized and subjected 
to statistical analysis. The differentially regulated genes were subjected to Ingenuity Pathway 
Analysis (IPA®). The expression of the differentially regulated genes identified by IPA® were 
verified using real-time polymerasechain reaction (RT-PCR).
Results: Supplementation with shilajit for 14 weeks was not associated with any reported 
adverse effect within this period. At a higher dose (250 mg bid), shilajit improved skin perfusion 
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when compared to baseline or the placebo. Pathway analysis identified shilajit-inducible genes 
relevant to endothelial cell migration, growth of blood vessels, and ECM which were validated by 
quantitative real-time polymerasechain reaction (RT-PCR) analysis.
Conclusions: This work provides maiden evidence demonstrating that oral shilajit 
supplementation in adult healthy women induced genes relevant to endothelial cell migration and 
growth of blood vessels. Shilajit supplementation improved skin microperfusion.
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Introduction
Shilajit is a resinous blackish-brown sticky tar-like herbomineral exudate that seeps from 
sedimentary rocks of steep mountainous regions and has reported medicinal properties (1, 
2). Although geographic and environmental factors determine the composition of shilajit (1, 
3), chemical characterization of shilajit has revealed the presence of three major components 
as represented by dibenzo-α-pyrones (DBPs, also known as urolithins in free form as well as 
conjugated with chromoproteins), fulvic acid with DBP core nucleus, and humic acid (2, 3). 
Shilajit and its active constituents have been reported to possess an array of pharmacological 
properties including adaptogenic, antioxidant, anti-inflammatory, immunomodulatory, anti-
diabetic, and neurological properties (4, 5).
Skin aging is characterized by wrinkles, dryness, laxity, thinning, irregular pigmentation, 
and loss of elasticity (6). Decrease in dermal thickness and vascularity is a hallmark of 
cutaneous aging (7). Aging is associated with decreased cutaneous perfusion (8). Dietary 
supplements show promise in preventing and managing serious health conditions. The 
present study was aimed at determining the effect of supplementing with a standardized 
shilajit extract on skin gene expression profile and related function.
Materials and methods
Shilajit (PrimaVie® Shilajit) capsules (125 mg referred to as S125, 250 mg referred to as 
S250) and placebo were provided by Natreon, Inc.. PrimaVie® Shilajit (U.S. patents: US 
6,869,612, and 6,558,712) is a purified and standardized shilajit extract and contains at least 
60% fulvic acid and equivalents with high levels of DBPs and DBP chromoproteins (9, 10, 
18). Each capsule contained standard components including gelatin, microcrystalline 
cellulose, croscarmellose sodium, fumed silicon-dioxide, and magnesium stearate as 
excipients, which are of national formulary grade.
Study subjects and experimental design
Study protocols (clinicaltrials.gov NCT02762032) and materials were approved by the 
Western Institutional Review Board. Written informed consent was collected from all 
subjects before participation in the study. Female subjects aged between 30 and 65 were 
included in the study. Three groups (each with n = 15) of subjects were randomized 
(www.random.org). Supplement randomization was done at study visit 1 and distribution of 
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the supplements were done at each study visit. During each visit, imaging and skin 
assessment were performed. Group 1 received placebo capsules; Groups 2 and 3 received 
125 mg or 250 mg capsules of shilajit bid, respectively. Oral supplementation was continued 
for 14 weeks and six assessment visits were performed during the duration of study. The 
study design comprised six visits—visit 1: baseline; visits 2 through 6: after 2, 4, 8, 12, and 
14 weeks of oral supplement of shilajit, respectively. During the study visit, the dietary and 
medical history and medications were recorded. Digital photographs of the face (left, right, 
and front views) were taken using a DSLR camera (Nikon D80 with 55–300mm lens) with 
neutral expressions without skin makeup. Noninvasive measurements such as transepidermal 
water loss (TEWL), hydration, elasticity, and dermascopic image were recorded with 
Dermalab (cyberDERM, Inc.) (11, 12). During visits 2 and 6, a skin biopsy of the left inner 
upper arm was taken. Review of adverse events and supplement count/compliance were 
performed. Any self-reported deviations were documented. Subjects using medications for 
cardiovascular disease–related disorders (hydrochlorothiazide, aspirin, steroids, ACE 
inhibitors, beta-blockers, and statins) were excluded from the study. Pregnant females and 
individuals receiving treatment for being immunocompromised were also not included in the 
study. The demographics of participating subjects are presented in Table 1.
Dermascopic image processing
A MATLAB (Mathworks Inc.) program code was developed for this study Supplemental 
data 1. Images from the dermascopic imaging system were processed to multicolor coded 
images which were used for the detection of skin microperfusion (13–15). Regions of 
interest (ROIs) were traced and signal intensity was computed. Two-dimensional (2-D) 
‘trapz()’ MATLAB function algorithm was used to calculate the area under the curve (AUC) 
by integrating intensity units over area of interest, which is a measure of total energy over 
the ROI.
Safety monitoring
No adverse effect was reported that was directly related to the dietary supplement.
Skin biopsy collection
Biopsy site was the left inner arm. Biopsy specimens were taken with a 3 mm punch from 
the upper inner left arm at week 2 and week 14. Wound care materials and care instructions 
were provided to the subjects. Due to practical limitations, biopsies could not be collected 
on visit 1. Biopsy specimens were processed for GeneChip® analysis and mRNA expression 
using quantitative real-time polymerase chain reaction (RT-PCR).
GeneChip® probe array analyses
GeneChip® analysis was done using Affymetrix Clariom™ D Assay as described previously 
(16–19) to identify sets of genes differentially expressed in the skin samples at different 
visits. Briefly, total RNA was isolated using the mirVana Isolation Kit as per the 
manufacturer’s protocol (Thermo Fisher Scientific) (18, 20, 21). RNA integrity was assessed 
using the Agilent 2100 Bioanalyzer. The isolated RNA was used to generate ss-cDNA using 
the GeneChip® WT PLUS reagent kit. Biotin-labeled ss-cDNA was hybridized, washed, and 
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stained on the Affymetrix Fluidics Station 450 according to the manufacturer’s protocol and 
scanned with the Affymetrix GeneChip Scanner 3000 7 G (16–18) The expression data have 
been submitted to Gene Expression Omnibus (GEO) at NCBI (http://www.ncbi.nlm.nih.gov/
geo/; series accession number GSE114170). Data files were generated and processed with 
Affymetrix software and Expression Console. Differentially expressed genes were identified 
using a two-class t test where significance level was set at p < 0.05 with Benjamini-
Hochberg correction for false discovery rate (16, 18). Significantly differentially regulated 
coding genes were subjected to functional analysis using Ingenuity® Pathway Analysis as 
previously described (22).
Validation of microarray results using quantitative RT-PCR
For gene expression, total cDNA was synthesized using the SuperScript III First Strand 
Synthesis System (Thermo Fisher Scientific) (23). Candidate genes were verified by RT-
PCR by using SYBR green-I and primers as previously described using β-actin as a 
housekeeping gene (20, 21, 24–27).
Statistical analysis
Data analysis was performed in a blinded fashion. Since fold-change values used for 
statistical analysis were highly skewed and non-normal, the values were transformed using 
natural logarithm. The transformed values were then used for all subsequent analyses. Paired 
two-tailed t tests were used to determine significant differences across baseline (or visit 2 for 
RT-PCR) and final visit (visit 6) for each subject in all the groups: Placebo, S125, and S250. 
Next, to detect the efficiency of the treatment with respect to the placebo, two-sample one-
tailed t tests were used on the log-transformed fold-change values from the final visit in each 
group. p < 0.05 was considered statistically significant.
Results
Shilajit supplementation increased skin microperfusion
Dermascopic images were used to determine whether shilajit supplementation (Figure 1A) 
had any effect on skin blood microperfusion. Increased reddish hue of the skin as detected 
using MATLAB color-coded images indicated improved skin microperfusion (Figure 1B-E). 
Interestingly, oral Shilajit increased skin redness at a 250 mg dose. However, shilajit did not 
influence skin perfusion at a 125 mg dose (Figure 1).
Transcriptome profiling of skin following oral shilajit supplementation
Skin samples were collected at visit 2 and visit 6. RNA extraction and target labeling were 
done, and GeneChip® data analysis was performed using Affymetrix Clariom™ D Assay 
(28) as described previously (16, 17) to determine the changes in the transcriptome of skin in 
response to oral shilajit supplementation. The high-resolution array design contains more 
than 6.0 million probes including coding transcripts and non-coding transcripts of which 
70% cover exons for coding transcripts, and the remaining 30% cover exon-exon splice 
junctions and non-coding transcripts (28). A total of ~ 5000 annotated probe sets were 
differentially (p < 0.05) regulated following 14-week supplementation (250 mg bid) as 
compared to placebo (Figure 2).
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Pathway analysis and validation using RT-PCR
Ingenuity® Pathway Analysis (IPA®) is a powerful analysis and search tool that assists in 
evaluating the significance of “omics” data identifying novel mechanistic pathways. IPA 
analysis identified an extracellular matrix (ECM)–related cluster of probe sets that was 
significantly upregulated in visit 6 of the shilajit-supplemented group as compared to visit 6 
of the placebo group (Figure 3). Among these upregulated genes, Col1A1, Col5A2, and 
Col14A1 were found to be significantly increased following shilajit supplementation as 
verified using quantitative RT-PCR (Figure 4). In addition, IPA analysis between visit 2 and 
visit 6 of the shilajit-supplemented group (250 mg bid) revealed upregulated genes involved 
in growth of blood vessels and movement of vascular endothelial cells upon shilajit 
supplementation (Figure 5A). TGFb1 and VEGFA path of vascularization was induced by 
shilajit supplementation (Figure 5B and C). These genes involved in the growth of blood 
vessels and endothelial cell migration included ITGA5, JAM3, LGALS1, LOX, MMP2, 
PDGFRB, PRKG1, RECK, SERPINF, SPARC, THBS2, TIMP1, TNN, and TIMP2. The 
expression of these genes was verified using quantitative RT-PCR (Figures 6 and 7) and was 
found to be upregulated in response to shilajit supplementation.
Shilajit supplementation did not adversely affect skin properties
Digital macrophotography and dermascopic imaging were performed on both left and right 
cheeks using the DermaLab Combo® device to determine the effect of shilajit 
supplementation on the properties of the skin. Trans-epidermal water loss (TEWL), an index 
for skin barrier function, surface electrical capacitance for skin hydration, and skin elasticity 
for tissue stiffness were measured to assess the effect of shilajit supplementation on skin. 
Analysis of TEWL revealed that there was no difference in the skin integrity in the treated 
groups compared to the placebo group (Figure 8), indicating that the supplement intake did 
not affect the barrier function of the skin. Similarly, there was no significant difference in the 
hydration, elasticity, viscoelasticity, and retraction time (Figure 8), establishing that shilajit 
supplementation did not adversely affect the quality of the skin. Thus, shilajit 
supplementation was safely tolerated.
Discussion
Skin microcirculation has a major thermoregulatory function, a nutritional role, and 
implications in cutaneous aging (29). A decrease in dermal vascularity is commonly 
encountered during cutaneous aging (7). Compromised circulation in the skin may cause 
cosmetic defects like unattractive skin tone and discoloration (8). The aged skin suffers from 
compromised sympathetic reflex as manifested by inability to vasoconstrict or vasodilate in 
response to changes in environmental temperature (30). In the cosmetic market, 
nutraceuticals play a major role (31–34). However, the scientific literature on the mechanism 
of action of such off-the-shelf nutraceuticals is scanty (35–37). Human studies must test not 
only efficacy but also safety of nutraceuticals because use of inappropriate supplements is 
known to pose risk to human health (38, 39). In this work, supplementation of shilajit to 
middle aged women for 14 weeks did not result in any reported adverse effects. 
Furthermore, basic skin function tests demonstrated no adverse effect of shilajit on skin 
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health in middle-aged women. Our findings are consistent with previous findings that have 
demonstrated the safety of shilajit (40, 41).
The dietary supplement L-arginine improved microperfusion of the rat skin (42). 
Consistently, transdermal delivery of L-arginine improved cutaneous blood flow in the feet 
of diabetic patients (43). Significant improvement of reddish coloration of the face under 
standardized testing conditions provided the first line of evidence suggesting that shilajit 
may improve skin microcirculation. Follow-up on this line of finding was performed by 
collection of skin biopsy and unbiased query of the human skin transcriptome. Additional 
validation of the findings of such screening was performed using quantitative polymerase 
chain reaction (PCR). Ingenuity pathway analyses of GeneChip® data identified genes 
related to endothelial cell migration and growth of blood vessels, being significantly induced 
in response to shilajit supplementation. Both of these functions are known to be directly 
responsible for skin angiogenesis (44). Statistical treatment of large data sets such as those 
acquired by GeneChip® include conservative measures to manage risks of false discovery 
(16, 18, 45). Using such conservative analyses and quantitative PCR analyses, it was noted 
that shilajit was effective in the induction of such genes. Angiogenesis is a well-regulated 
physiological process that includes blood vessel formation followed by timely regression 
(46, 47). Consistent with that notion, the current work reports the induction of angiogenic 
mediators as well as anti-angiogenic pathways that are necessary for regression. 
Interestingly, the application of rigorous quantitative PCR revealed that shilajit was more 
effective at the lower dosage studied (125 mg bid). Such dose–effect response is not 
uncommon, as reported previously (48–51).
ECM provides scaffold support as well as biochemical cues for skin cells to grow and is 
recognized as a major determinant of skin health (52). Age-related decay of ECM accounts 
for skin thinning and wrinkles (7). In the current study, upregulation of the ECM genes, 
Col1A1, Col5A2, and Col14A1 was statistically significant upon shilajit supplementation. 
Collagens constitute a major component of skin ECM and provide structural support as well 
as molecular signals to resident cells (27, 52). A recent study addressing the mechanism of 
action of shilajit in improving human skeletal muscle adaptation to exercise provided first 
evidence on shilajit-induced expression of ECM-related genes (18). Shilajit supplementation 
significantly increased ECM-related gene expression in overweight/class I obese human 
subjects. is evident across independent studies that when taken orally Of interest, exercise 
and shilajit were synergistic in shilajit modifies organ ECM composition. In the skeletal 
upregulating collagen and other ECM proteins (18). Thus, it muscle, ECM is known to play 
an essential role in the development, maintenance, and regeneration of the organ well as 
ECM-related genes is of particular significance (53, 54). The observation that shilajit 
induced genes involved because these two functional domains of tissue biology are in 
growth of blood vessels and endothelial cell migration as known to be directly related (55, 
56).
Conclusion
The current study provides interesting insight into the mechanism of action of shilajit on 
human skin health. The findings of this work therefore lays the rationale for further 
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mechanistic studies addressing shilajit-inducible signaling pathways that are common to 
both vascular and ECM function.
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Shilajit improves skin microperfusion. A, Study design. B, Dermascopic images of the 
cheek. C, MATLAB multicolor coded dermascopic images. D, 3-D scatterplot of the Visible 
Bands of MATLAB processed dermascopic images. E, The sum of the area under the curve 
of red and green channels were plotted graphically. The intensity of the red and green 
channels was calculated from the multicolor images processed by MATLAB software from 
the raw dermascopic images. S125 represents shilajit 125 mg and S250 represents shilajit 
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250 mg. Data are mean ± SEM (n = 13). *p < 0.05 compared to the baseline visit. †p < 0.05 
compared to placebo.
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Heat map illustrating cluster of transcripts sensitive to shilajit supplementation (250 mg bid). 
Shilajit-sensitive transcripts were subjected to hierarchical clustering. A, Heat map 
illustrating cluster of transcripts that were upregulated upon shilajit supplementation. B, 
Heat map (top 100 candidates) demonstrating cluster of transcripts that were upregulated 
upon shilajit supplementation.
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A and B, Ingenuity pathway analysis (IPA) showing that the supplementation of shilajit 
induces ECM-related genes.
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RT-PCR validation of ECM-related genes following oral shilajit supplementation. 
Expression levels of selected genes identified by IPA were independently verified using 
quantitative real-time PCR. S125 represents shilajit 125 mg and S250 represents shilajit 250 
mg. Data are mean ± SEM (n = 10–13). *p < 0.05 compared to visit 2. †p < 0.05 compared 
to placebo.
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Ingenuity pathway analysis (IPA) showing that the supplementation of shilajit increases 
genes involved in the (A) movement of endothelial cells and growth of blood vessels through 
the (B) VEGFA and (C) TGFβ1 pathway.
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RT-PCR validation of genes related to movement of endothelial cells following oral shilajit 
supplementation. Expression levels of selected genes identified by IPA were independently 
verified using quantitative real-time PCR. S125 represents shilajit 125 mg and S250 
represents shilajit 250 mg. Data are mean ± SEM (n = 10–13). *p < 0.05 compared to visit 2. 
†p < 0.05 compared to placebo.
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RT-PCR validation of genes related to growth of blood vessels following oral shilajit 
supplementation. Expression levels of selected genes identified by IPA were independently 
verified using quantitative real-time PCR. S125 represents shilajit 125 mg and S250 
represents shilajit 250 mg. Data are mean ± SEM (n = 10–13). *p < 0.05 compared to visit 2. 
†p < 0.05 compared to placebo.
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Shilajit is safe for facial skin. A, TEWL; B, hydration; C, elasticity (E); D, viscoelasticity 
(VE); and E, retention time was measured using Dermalab combo®. S125 represents shilajit 
125 mg and S250 represents shilajit 250 mg. Data are mean ± SEM (n = 13–14).
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Age (years) 42.09 ± 1.17
Body weight (kg) 76.24 ± 2.75





J Am Coll Nutr. Author manuscript; available in PMC 2020 August 01.
